ArticleRespiratory medicine case reports2020
Good response with durvalumab after chemoradiotherapy for epidermal growth factor receptor exon 20 insertion adenocarcinoma: A case report.
Shun Matsuura et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.